H|T: The Healthtech Times – Blunder drug

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!

MCI Onehealth closes $30 million CAD initial public offering (BETAKIT)

MCI Onehealth, a Toronto-based healthtech company, has closed $30 million CAD for its initial public offering (IPO).


Why San Francisco-based VC Hustle Fund Is Betting Big on Canada

“At Hustle Fund, we’re convinced that Canada is positioned well to produce some of the largest, category-defining companies on the planet. We’re eager to fund these companies, and excited to partner with Hockeystick to identify these opportunities!” – Eric Bahn (General Partner)

Since launch, Hockeystick has made over 6000 funder recommendations to Canadian startups. Learn how startups are using technology to meet funders around the world.

Why a homegrown coronavirus wonder drug fell flat (THE GLOBE AND MAIL)

Provincial health ministries and front-line doctors are rejecting Bamlanivimab, saying the scientific evidence is too thin and the intravenous delivery method too difficult to pull off during a health care crisis.

Tech companies join effort focused on COVID-19 vaccine records (WALL STREET JOURNAL)

Businesses including Microsoft Corp., Oracle Corp. and Cerner Corp. are working with health groups on an effort to help people easily show they have received a COVID-19 vaccine.

Google closes Fitbit acquisition — without DOJ approval (MED CITY NEWS)

Google announced it had closed its planned acquisition of Fitbit, even thought the deal is still being investigated by the U.S. Department of Justice.

Health benefits platform Accolade is buying telehealth startup 2nd.MD for $460M (FIERCE HEALTHCARE)

Accolade plans to pay $460 million to acquire 2nd.MD, a company that helps patients get expert medical opinions via video or phone.

Deloitte to track Canada’s COVID-19 vaccination efforts (THE GLOBE AND MAIL)

As the vaccination campaign kicks into high gear, a lack of digitization could create bottlenecks in the system.

AI cancer pathology developer Paige nets $100M in venture capital funding (FIERCE BIOTECH)

The New York-based company’s series C round was led by Casdin Capital and Johnson & Johnson Innovation, the drugmaker’s strategic venture capital arm.

Amalgam Rx buys clinical decision support company Avhana Health (MOBIHEALTHNEWS)

Avhana’s platform is able to integrate into provider’s EHRs and suggest treatments, including digital.

Pace launches out of private beta with a plan to scale virtual group therapy (TECHCRUNCH)

One in five people have a mental health illness. Pace, a new startup founded by Pinterest and Affirm executives, wants to pay attention to the other four in that statistic.

Caitlin Hotchkiss

Caitlin Hotchkiss

Content coordinator, social media smartypants, wordsmith, Human Workflow™. Exists primarily on coffee, cat pictures, German dance metal, and pro wrestling. I will fight for your right to the Oxford comma.

0 replies on “H|T: The Healthtech Times – Blunder drug”